Chester County News and Community Website
WILMINGTON, DE — The Chemours Company (NYSE: CC) has entered a strategic agreement with Navin Fluorine International Limited (NSE: NAVINFLUOR) to manufacture Opteon™ two-phase immersion cooling fluid. This collaboration forms …
Chemours Partners with Navin Fluorine to Revolutionize Data Center Cooling Read More
WILMINGTON, DE — Global Indemnity Group, LLC (NYSE: GBLI) announced a net loss of $4.1 million, or $0.30 per share, for the first quarter of 2025, primarily driven by losses …
Global Indemnity Group Reports Q1 2025 Results, Details Wildfire Impact Read More
WILMINGTON, DE — Positive results from the DESTINY-Breast11 Phase III trial revealed that ENHERTU® (fam-trastuzumab deruxtecan-nxki), when followed by paclitaxel, trastuzumab, and pertuzumab (THP), significantly improved pathologic complete response (pCR) …
ENHERTU Shows Promise in Early-Stage HER2-Positive Breast Cancer Read More WILMINGTON, DE — The Chemours Company (NYSE: CC) has released its financial results for the first quarter of 2025. The company reported net sales of $1.4 billion, consistent with the …
Chemours Reports Q1 2025 Financial Results, Highlights Strategic Initiatives Read More
WILMINGTON, DE — Acorn Energy, Inc. (OTCQB: ACFN) posted strong financial results for the first quarter of 2025, showcasing significant revenue growth driven by its major contract with a leading …
Acorn Energy Reports Q1 2025 Growth and Nasdaq Uplisting Plans Read More
WILMINGTON, DE — Enovis™ Corporation (NYSE: ENOV) reported robust financial results for the first quarter ended April 4, 2025, showcasing steady growth across key segments and improved margins. The company …
Enovis Reports Strong Q1 2025 Results, Updates Financial Outlook Read More
WILMINGTON, DE — Prelude Therapeutics Incorporated (Nasdaq: PRLD) released its first-quarter financial results, showcasing operational progress and updates across its clinical pipeline.
Prelude Therapeutics Reports Q1 2025 Financial Results and Progress on Clinical Programs Read More
WILMINGTON, DE — Ashland Inc. (NYSE: ASH) has announced that Kevin Willis, senior vice president and chief financial officer, will leave the company on May 16, 2025, to pursue another …
Ashland Announces CFO Transition and Interim Leadership Appointments Read More WILMINGTON, DE — AstraZeneca has announced positive high-level results from its Phase III KALOS and LOGOS trials, showing significant promise for its fixed-dose triple-combination therapy, BREZTRI AEROSPHERE (budesonide/glycopyrronium/formoterol fumarate or …
AstraZeneca Reports Promising Phase III Trial Results for BREZTRI AEROSPHERE Read More
WILMINGTON, DE — A Thursday evening shooting in Wilmington left one man dead and two others injured, including a child. The incident occurred at approximately 6:44 p.m. on May 8, …
Wilmington Shooting Leaves One Dead and Two Injured Read More